IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn's and Colitis
An alliance of clinicians, academics, research nurses, funders, coordinators, programmers and, most importantly, patients has come together in the UK to deliver a powerful new platform to accelerate Crohn’s and Colitis research—the inflammatory bowel disease (IBD) BioResource. As part of the Nationa...
Main Authors: | Parkes, M, IBD BioResource Investigators |
---|---|
Other Authors: | Jostins-Dean, L |
Format: | Journal article |
Language: | English |
Published: |
BMJ
2019
|
Similar Items
-
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease.
by: Parkes, M, et al.
Published: (2000) -
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
by: Cassinotti, A, et al.
Published: (2009) -
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
by: Van Assche, G, et al.
Published: (2011) -
Endoscopic features of non-IBD colitis
by: Flavia Pigò, et al.
Published: (2023-12-01) -
Participation in the BioResource. Biobanking and Value in the Changing NHS
by: David Wyatt, et al.
Published: (2019-01-01)